But we did not observe any significant changes of proliferation and migration in tumor cells after treated with NAD+ precursor NMN or ADO (Fig. S3B, C), indicated that CD38 might regulate tumor cell proliferation and migration independent on ADO and NAD+. Here, CD38 is linked to neoplasm.